Processa Pharmaceuticals, Inc.
PCSA· Nasdaq
Processa Pharmaceuticals, Inc.
- Last sale
- Oct 2, 2026 · +1.17%
- Market cap
- $4.83M
- 2.79M shares
- Filings
- 695
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2022 | 2022-12-31 | $0 | reported | |
| FY 2021 | 2021-12-31 | $0 | reported | |
| FY 2016 | 2016-12-31 | $5,000 | reported | |
| FY 2015 | 2015-12-31 | $113,425 | reported | |
| FY 2014 | 2014-12-31 | $107,239 revised | reported | |
| FY 2013 | 2013-12-31 | $312,480 | reported | |
| FY 2012 | 2012-12-31 | $192,145 | reported |
Processa Pharmaceuticals, Inc. · CIK 1533743 · Engraved from SEC EDGAR
